Lack of TCF2/vHNF1 in Mice Leads to Pancreas Agenesis
Haumaitre, C., Barbacci, E., Jenny, M., Ott, M. O., Gradwohl, G., Cereghini, S., Anderson, Kathryn V.
Published in Proceedings of the National Academy of Sciences - PNAS (01.02.2005)
Published in Proceedings of the National Academy of Sciences - PNAS (01.02.2005)
Get full text
Journal Article
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
MOYER, J. D, BARBACCI, E. G, NEVEU, M, POLLACK, V. A, PUSTILNIK, L. R, REYNOLDS, M. M, SLOAN, D, THELEMAN, A, MILLER, P, IWATA, K. K, ARNOLD, L, BOMAN, B, CUNNINGHAM, A, DIORIO, C, DOTY, J, MORIN, M. J, MOYER, M. P
Published in Cancer research (Chicago, Ill.) (01.11.1997)
Get full text
Published in Cancer research (Chicago, Ill.) (01.11.1997)
Journal Article
Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification
Barbacci, E, Reber, M, Ott, M O, Breillat, C, Huetz, F, Cereghini, S
Published in Development (Cambridge) (01.11.1999)
Published in Development (Cambridge) (01.11.1999)
Get full text
Journal Article
The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells
BARBACCI, E. Gabriella, PUSTILNIK, Leslie R, KATH, John C, ZHENGYU LIU, MOYER, James D, ROSSI, Ann Marie K, EMERSON, Erling, MILLER, Penny E, BOSCOE, Brian P, COX, Eric D, IWATA, Kenneth K, JANI, Jitesh P, PROVONCHA, Kathleen
Published in Cancer research (Chicago, Ill.) (01.08.2003)
Get full text
Published in Cancer research (Chicago, Ill.) (01.08.2003)
Journal Article
Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice
Pollack, V A, Savage, D M, Baker, D A, Tsaparikos, K E, Sloan, D E, Moyer, J D, Barbacci, E G, Pustilnik, L R, Smolarek, T A, Davis, J A, Vaidya, M P, Arnold, L D, Doty, J L, Iwata, K K, Morin, M J
Published in The Journal of pharmacology and experimental therapeutics (01.11.1999)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.11.1999)
Journal Article
ERBB-2 ONCOGENE INHIBITION BY GELDANAMYCIN DERIVATIVES - SYNTHESIS, MECHANISM OF ACTION, AND STRUCTURE-ACTIVITY-RELATIONSHIPS
SCHNUR, RC, CORMAN, ML, GALLASCHUN, RJ, COOPER, BA, DEE, MF, DOTY, JL, MUZZI, ML, DIORIO, CI, BARBACCI, EG, MILLER, PE, POLLACK, VA, SAVAGE, DM, SLOAN, DE, PUSTILNIK, LR, MOYER, JD, MOYER, MP
Published in Journal of medicinal chemistry (15.09.1995)
Published in Journal of medicinal chemistry (15.09.1995)
Get full text
Journal Article
Inflammatory Mediators Increase Surface Expression of Integrin Ligands, Adhesion to Lymphocytes, and Secretion of Interleukin 6 in Mouse Sertoli Cells
Riccioli, Anna, Filippini, Antonio, De Cesaris, Paola, Barbacci, Elena, Stefanini, Mario, Starace, Giuseppe, Ziparo, Elio
Published in Proceedings of the National Academy of Sciences - PNAS (20.06.1995)
Published in Proceedings of the National Academy of Sciences - PNAS (20.06.1995)
Get full text
Journal Article
Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network
Tzahar, Eldad, Moyer, James D., Waterman, Hadassa, Barbacci, Elsa G., Bao, Jing, Levkowitz, Gil, Shelly, Maya, Strano, Sabrina, Pinkas-Kramarski, Ronit, Pierce, Jacalyn H., Andrews, Glenn C., Yarden, Yosef
Published in The EMBO journal (15.10.1998)
Published in The EMBO journal (15.10.1998)
Get full text
Journal Article
INHIBITION OF THE ONCOGENE PRODUCT P185(ERBB-2) IN-VITRO AND IN-VIVO BY GELDANAMYCIN AND DIHYDROGELDANAMYCIN DERIVATIVES
SCHNUR, RC, CORMAN, ML, GALLASCHUN, RJ, COOPER, BA, DEE, MF, DOTY, JL, MUZZI, ML, MOYER, JD, DIORIO, CI, BARBACCI, EG, MILLER, PE, OBRIEN, AT, MORIN, MJ, FOSTER, BA, POLLACK, VA, SAVAGE, DM, SLOAN, DE, PUSTILNIK, LR, MOYER, MP
Published in Journal of medicinal chemistry (15.09.1995)
Published in Journal of medicinal chemistry (15.09.1995)
Get full text
Journal Article
The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding
Barbacci, E G, Guarino, B C, Stroh, J G, Singleton, D H, Rosnack, K J, Moyer, J D, Andrews, G C
Published in The Journal of biological chemistry (21.04.1995)
Published in The Journal of biological chemistry (21.04.1995)
Get full text
Journal Article
Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives
Schnur, R. C, Corman, M. L, Gallaschun, R. J, Cooper, B. A, Dee, M. F, Doty, J. L, Muzzi, M. L, Moyer, J. D, DiOrio, C. I
Published in Journal of medicinal chemistry (01.09.1995)
Published in Journal of medicinal chemistry (01.09.1995)
Get full text
Journal Article
erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships
Schnur, R. C, Corman, M. L, Gallaschun, R. J, Cooper, B. A, Dee, M. F, Doty, J. L, Muzzi, M. L, DiOrio, C I, Barbacci, E. G
Published in Journal of medicinal chemistry (01.09.1995)
Published in Journal of medicinal chemistry (01.09.1995)
Get full text
Journal Article
3-(4-Chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-a-pentenonitrile monohydrogen citrate and related analogs: Reversible, competitive, first half-reaction squalene synthetase inhibitors
Harwood, H.James, Barbacci-Tobin, Elsa G., Petras, Stephen F., Lindsey, Saralyn, Pellarin, Lorraine D.
Published in Biochemical pharmacology (21.03.1997)
Published in Biochemical pharmacology (21.03.1997)
Get full text
Journal Article
Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor
Jani, J., Barbacci, E., Bhattacharya, S., Boos, C., Campbell, M., Clark, T., Coleman, K., Connell, R., Cosker, T.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor
Jani, J., Barbacci, E., Bhattacharya, S., Boos, C., Campbell, M., Clark, T., Coleman, K., Connell, R., Cosker, T.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article